AN2 Therapeutics, Inc. 8-K

Accession 0001193125-26-149822

Filing information

CIK: 0001880438
Report date: 2026-04-09
Filing date: 2026-04-09
Form: 8-K
Primary document: d127053d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.